Focused research review
Endocannabinoids and endocannabinoid-like lipids: what the research says
What evidence defines endogenous cannabinoids and endocannabinoid-like lipids relevant to the encyclopedia?
The short answer
What is the bottom line?
Research has examined Endocannabinoids and endocannabinoid-like lipids. This page brings together 2 human-study sources, 7 research reviews, and 1 lab, animal, or mechanism source. The source set includes human research as well as earlier-stage studies. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1
Key takeaways
What to know first
- 1
Research on Endocannabinoids and endocannabinoid-like lipids covers Endocannabinoids and endocannabinoid-like lipids research topics; those areas should not be combined into one claim. 1
- 2
The source set includes human research as well as earlier-stage studies. 2
- 3
Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3
Research areas
What researchers studied about Endocannabinoids and endocannabinoid-like lipids
These are the main questions represented in the current literature. Each link opens a source used to build the overview.
Too limited for a firm answer
Endocannabinoids and endocannabinoid-like lipids research topics
This part of the literature focuses on Endocannabinoids and endocannabinoid-like lipids research topics. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 1
How strong is the research?
Not every study answers the same question
This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.
Human studies
Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.
Reviews and evidence summaries
Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.
Lab, animal, and mechanism research
Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.
Another 3 of 13 research sources could not be placed cleanly into those three groups from the recorded study details.
What these studies actually looked at
The research on Endocannabinoids and endocannabinoid-like lipids is not one kind of study. This source set includes 7 narrative or expert reviews and 2 cell or laboratory studies. 3
The recorded populations or models include cells or tissue models (5 sources) and people or patients (2 sources). A result from one group or model should not be assumed to apply to another. 4
The most common recorded outcome focus is endocannabinoids and endocannabinoid-like lipids research topics (13 sources). Closely related outcome names can still describe different measurements. 5
The Endocannabinoids and endocannabinoid-like lipids source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6
Examples from the literature
What did the studies actually look at?
Each example names the research question and the study details recorded for that source.
narrative or expert review
An Introduction to the Endogenous Cannabinoid System.
On this page, this source examines THC and endocannabinoids and endocannabinoid-like lipids research topics. 1
- Study type
- narrative or expert review
- Outcome focus
- endocannabinoids and endocannabinoid-like lipids research topics
- Evidence stage
- evidence still limited
cell or laboratory study
Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB1, TRPV1, and PPARα.
On this page, this source examines Endocannabinoids and endocannabinoids and endocannabinoid-like lipids research topics. 2
- Study type
- cell or laboratory study
- Population or model
- cells or tissue models
- Outcome focus
- endocannabinoids and endocannabinoid-like lipids research topics
- Evidence stage
- mechanism-focused research
human research
Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification of Four Endocannabinoids and Endocannabinoid-Like Substances in Plasma: Application in an HIV-Hepatitis C Virus Coinfected Population.
On this page, this source examines Endocannabinoids and endocannabinoids and endocannabinoid-like lipids research topics. 3
- Population or model
- people or patients
- Outcome focus
- endocannabinoids and endocannabinoid-like lipids research topics
- Evidence stage
- human research
narrative or expert review
Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.
On this page, this source examines THC and endocannabinoids and endocannabinoid-like lipids research topics. 4
- Study type
- narrative or expert review
- Population or model
- cells or tissue models
- Outcome focus
- endocannabinoids and endocannabinoid-like lipids research topics
- Evidence stage
- evidence still limited
narrative or expert review
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.
On this page, this source examines THC and endocannabinoids and endocannabinoid-like lipids research topics. 5
- Study type
- narrative or expert review
- Population or model
- cells or tissue models
- Outcome focus
- endocannabinoids and endocannabinoid-like lipids research topics
- Evidence stage
- evidence still limited
Safety and limits
What should readers keep in mind?
Research on Endocannabinoids and endocannabinoid-like lipids should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2
Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.
Common questions
Questions people ask
What evidence defines endogenous cannabinoids and endocannabinoid-like lipids relevant to the encyclopedia?
Relevant research is collected here. The source set includes human research as well as earlier-stage studies. 7
Why is there not always a yes-or-no answer?
The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8
Where can I read the original studies?
Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9
Sources
Read the research
The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.
-
1
An Introduction to the Endogenous Cannabinoid System. narrative or expert review; evidence still limited PubMed 26698193 DOI 10.1016/j.biopsych.2015.07.028
-
2
Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB1, TRPV1, and PPARα. cell or laboratory study; mechanism-focused research PubMed 31325449 DOI 10.1016/j.bcp.2019.07.017
-
3
Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification of Four Endocannabinoids and Endocannabinoid-Like Substances in Plasma: Application in an HIV-Hepatitis C Virus Coinfected Population. human research PubMed 41035123 DOI 10.1097/ftd.0000000000001397
-
4
Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. narrative or expert review; evidence still limited PubMed 19833407 DOI 10.1016/j.imbio.2009.09.007
-
5
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. narrative or expert review; evidence still limited PubMed 17704824 DOI 10.1038/sj.bjp.0707423
-
6
Classical endocannabinoid-like compounds and their regulation by nutrients. narrative or expert review; evidence still limited PubMed 24677570 DOI 10.1002/biof.1158
-
7
Endocannabinoid Turnover. narrative or expert review; evidence still limited PubMed 28826539 DOI 10.1016/bs.apha.2017.03.006
-
8
Endocannabinoids. narrative or expert review; evidence still limited PubMed 9831287 DOI 10.1016/s0014-2999(98
-
9
The Endocannabinoid System and its Modulation by Phytocannabinoids. narrative or expert review; evidence still limited PubMed 26271952 DOI 10.1007/s13311-015-0374-6
-
10
Effects of fermentation and alkalisation on the formation of endocannabinoid-like compounds in olives. evidence still limited PubMed 38909454 DOI 10.1016/j.foodchem.2024.140164
-
11
Endocannabinoids, endocannabinoid-like compounds and cortisone in head hair of health care workers as markers of stress and resilience during the early COVID-19 pandemic. evidence still limited PubMed 38296973 DOI 10.1038/s41398-024-02771-9
-
12
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. cell or laboratory study; mechanism-focused research PubMed 17965195 DOI 10.1124/mol.107.041863
See all 13 research sources
This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.
- Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB1, TRPV1, and PPARα. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 31325449
- An Introduction to the Endogenous Cannabinoid System. narrative or expert review; evidence still limited / 1 linked research note PubMed 26698193
- The Endocannabinoid System and its Modulation by Phytocannabinoids. narrative or expert review; evidence still limited / 1 linked research note PubMed 26271952
- Endocannabinoid Turnover. narrative or expert review; evidence still limited / 1 linked research note PubMed 28826539
- Endocannabinoids. narrative or expert review; evidence still limited / 1 linked research note PubMed 9831287
- Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 17965195
- Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. narrative or expert review; evidence still limited / 1 linked research note PubMed 19833407
- Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. narrative or expert review; evidence still limited / 1 linked research note PubMed 17704824
- Classical endocannabinoid-like compounds and their regulation by nutrients. narrative or expert review; evidence still limited / 1 linked research note PubMed 24677570
- Effects of fermentation and alkalisation on the formation of endocannabinoid-like compounds in olives. evidence still limited / 1 linked research note PubMed 38909454
- Endocannabinoids, endocannabinoid-like compounds and cortisone in head hair of health care workers as markers of stress and resilience during the early COVID-19 pandemic. evidence still limited / 1 linked research note PubMed 38296973
- Roles of Endocannabinoids and Endocannabinoid-Like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective. evidence still limited / 1 linked research note PubMed 34115519
- Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification of Four Endocannabinoids and Endocannabinoid-Like Substances in Plasma: Application in an HIV-Hepatitis C Virus Coinfected Population. human research / 1 linked research note PubMed 41035123